Cost-Effectiveness of Multiple Sclerosis Therapies – A Literature Review Cover

.blurhash-client-img { display: none !important; }

Cost-Effectiveness of Multiple Sclerosis Therapies – A Literature Review

Acta Medica Bulgarica

Volume 49 (2022): Issue 4 (December 2022)

By: Y. Seitaridou, M. Dimitrova, T. Chamova, M. Kamusheva and P. Panayotov

Open Access

|Feb 2023

Authors

Y. Seitaridou

yoanaaaps@gmail.com

Department of Organization and Economics of Pharmacy, Faculty of Pharmacy, Medical University – Sofia, Bulgaria

M. Dimitrova

Department of Organization and Economics of Pharmacy, Faculty of Pharmacy, Medical University – Sofia, Bulgaria

T. Chamova

Clinic of Neurology, University Hospital “Alexandrovska” – Sofia, Bulgaria

M. Kamusheva

Department of Organization and Economics of Pharmacy, Faculty of Pharmacy, Medical University – Sofia, Bulgaria

P. Panayotov

Department of Organization and Economics of Pharmacy, Faculty of Pharmacy, Medical University – Sofia, Bulgaria

DOI: https://doi.org/10.2478/amb-2022-0046 | Journal eISSN: 2719-5384 | Journal ISSN: 0324-1750

Journal RSS Feed

Language: English

Page range: 69 - 80

Submitted on: Aug 29, 2022

|

Accepted on: Nov 3, 2022

|

Published on: Feb 10, 2023

Published by: Medical University - Sofia

In partnership with: Paradigm Publishing Services

Publication frequency: 4 issues per year

Keywords:

multiple sclerosis,

literature review,

cost-effectiveness,

Related subjects:

Basic medical science,

Clinical medicine,

Clinical medicine, other

© 2023 Y. Seitaridou, M. Dimitrova, T. Chamova, M. Kamusheva, P. Panayotov, published by Medical University - Sofia
This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 License.

Previous article Volume 49 (2022): Issue 4 (December 2022)